David Shang's Stock Coverage
| 2359WuXi AppTec Co., Ltd. Class H | Oct 29, 2026 | BUY | Reiterated | HK$215.00 | 2Ratings | +5.80% | ||
| 3347Hangzhou Tigermed Consulting Co., Ltd. Class H | Sep 02, 2026 | HOLD | Downgraded | HK$45.00 | 2Ratings | -5.70% | ||
| 1875TOT BIOPHARM International Co. Ltd. | Jun 08, 2026 | BUY | Reiterated | HK$4.40 | 1Ratings | -5.00% | ||
| 9860ADICON Holdings Limited | Mar 31, 2026 | BUY | Reiterated | HK$7.00 | 1Ratings | +7.10% | ||
| 2252Shanghai MicroPort MedBot (Group) Co., Ltd. Class H | Mar 30, 2026 | BUY | Reiterated | HK$40.00 | 4Ratings | -7.55% | ||
| 1789AK Medical Holdings Ltd. | Mar 30, 2026 | BUY | Reiterated | HK$7.50 | 2Ratings | +7.15% | ||
| 1066Shandong Weigao Group Medical Polymer Co | Mar 30, 2026 | BUY | Reiterated | HK$5.50 | 2Ratings | +3.30% | ||
| 3933The United Laboratories International Holdings | Sep 05, 2025 | BUY | Reiterated | HK$20.00 | 2Ratings | -35.55% | ||
| 1093CSPC Pharmaceutical Group | Jan 22, 2025 | HOLD | Reiterated | HK$4.60 | 1Ratings | ― | ― |
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed. See how TipRanks ranks experts and calculates performance.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >David Shang activity FAQ
What is the performance of David Shang's recommendations?
The percentage of profitable recommendations made by David Shang is 35.71%, and the average return per transaction is -5.50%.
What stocks does David Shang cover?
David Shang mostly covers WuXi AppTec Co., Ltd. Class H, Hangzhou Tigermed Consulting Co., Ltd. Class H, TOT BIOPHARM International Co. Ltd. stocks.
What was David Shang's most profitable rating?
David Shang’s most profitable rating was a buy on Shanghai MicroPort MedBot (Group) Co., Ltd. Class H stock on Jun 10, 2025. The return on the trade was 41.80%.
Where can I see a list of stock analyst ratings?
You can see a list of daily stock analyst ratings here.
What are the most recommended stocks by analysts?
You can see a list of the most recommended stocks by analysts here